Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: June 24, 2018

DrugPatentWatch Database Preview

Collegium Pharm Inc Company Profile

« Back to Dashboard

What is the competitive landscape for COLLEGIUM PHARM INC, and when can generic versions of COLLEGIUM PHARM INC drugs launch?

COLLEGIUM PHARM INC has one approved drug.

There are thirteen US patents protecting COLLEGIUM PHARM INC drugs.

There are sixteen patent family members on COLLEGIUM PHARM INC drugs in nine countries and one supplementary protection certificate in one country.

Summary for Collegium Pharm Inc

International Patents:	16
US Patents:	13
Tradenames:	1
Ingredients:	1
NDAs:	1

Drugs and US Patents for Collegium Pharm Inc

+ Get email alerts for changes to this table

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Collegium Pharm Inc	XTAMPZA ER	oxycodone	CAPSULE, EXTENDED RELEASE;ORAL	208090-001	Apr 26, 2016		RX	Yes	No	8,449,909	➤ Try a Free Trial	Y			➤ Try a Free Trial
Collegium Pharm Inc	XTAMPZA ER	oxycodone	CAPSULE, EXTENDED RELEASE;ORAL	208090-001	Apr 26, 2016		RX	Yes	No	8,557,291	➤ Try a Free Trial	Y			➤ Try a Free Trial
Collegium Pharm Inc	XTAMPZA ER	oxycodone	CAPSULE, EXTENDED RELEASE;ORAL	208090-002	Apr 26, 2016		RX	Yes	No		➤ Try a Free Trial				➤ Try a Free Trial
Collegium Pharm Inc	XTAMPZA ER	oxycodone	CAPSULE, EXTENDED RELEASE;ORAL	208090-002	Apr 26, 2016		RX	Yes	No	9,682,075	➤ Try a Free Trial	Y			➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

International Patents for Collegium Pharm Inc Drugs

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Country	Document Number	Estimated Expiration
Canada	2916869	➤ Try a Free Trial
European Patent Office	1765292	➤ Try a Free Trial
Japan	4694207	➤ Try a Free Trial
Japan	2013216707	➤ Try a Free Trial
Country	Document Number	Estimated Expiration

Supplementary Protection Certificates for Collegium Pharm Inc Drugs

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
292	Luxembourg	➤ Try a Free Trial	PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army

Accenture

Medtronic

Express Scripts

AstraZeneca

Colorcon

Merck

Mallinckrodt

Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.